Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
Today, potential immunogenicity can be better evaluated during the drug development process, and we have rational approaches to manage the clinical consequences of immunogenicity. The focus of the scientific community should be on developing sensitive diagnostics that can predict immunogenicity-medi...
Saved in:
| Main Authors: | Anshu Kuriakose, Narendra Chirmule, Pradip Nair |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2016/1298473 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
by: Agata N. Burska, et al.
Published: (2014-01-01) -
Landscape of Histone Posttranslational Modifications in Osteoarthritis
by: Zhao S, et al.
Published: (2025-06-01) -
Posttranslational Modification in Bone Homeostasis and Osteoporosis
by: Yuzhe Lin, et al.
Published: (2025-04-01) -
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities
by: Zhenxiong Zhang, et al.
Published: (2025-07-01) -
Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development
by: Yanmei Lu, et al.
Published: (2016-01-01)